Stock VPTDF VENTRIPOINT DIAGNOSTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Ventripoint Diagnostics Ltd. OTC Markets

Equities

VPTDF

CA92281P2008

Delayed OTC Markets
Other stock markets
 15:19:00 2024-07-16 EDT 		5-day change 1st Jan Change
0.1542 USD -3.62% Intraday chart for Ventripoint Diagnostics Ltd. -1.97% -32.43%
06-13 Ventripoint Diagnostics Ltd. Appoints Matt Dobson as Marketing Director CI
05-31 Ventripoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect
AQ
Ventripoint Diagnostics Ltd. Appoints Matt Dobson as Marketing Director
CI
Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
AQ
Ventripoint Diagnostics Announces Shareholder Update and Teleconference
AQ
Ventripoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ventripoint Diagnostics Ltd. Submits Next Generation of Software, VMS+4.0, to the U.S. Food and Drug Administration
CI
Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration
AQ
Duke University Health Center Purchases Ventripoint's AI Heart-Scan Technology
CI
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology
AQ
Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
VentriPoint Diagnostics Ltd. announced that it expects to receive CAD 3 million in funding
CI
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
AQ
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)
CI
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use
AQ
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences
CI
Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences
AQ
Ventripoint Announces Changes to The Board of Directors
AQ
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO
CI
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President
CI
Ventripoint Begins 2024 with Leadership Change
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VPT Stock
  4. VPTDF Stock
  5. News Ventripoint Diagnostics Ltd.